# Linzess

NDC: 0456-1201
Generic name: linaclotide
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20120908

FDA application: NDA202811

## Active ingredients

- LINACLOTIDE: 145 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0456-1201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0456-1201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3